BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of $28.42 billion. The enterprise value is $27.00 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BeiGene has 118.39 million shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 118.39M |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | -2.27% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 44.87% |
| Float | 75.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 94.97 |
| PS Ratio | 6.00 |
| Forward PS | 3.19 |
| PB Ratio | 7.41 |
| P/TBV Ratio | 8.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 174.42 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.95 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.93 |
Financial Efficiency
Return on equity (ROE) is -11.62% and return on invested capital (ROIC) is -3.86%.
| Return on Equity (ROE) | -11.62% |
| Return on Assets (ROA) | -3.06% |
| Return on Invested Capital (ROIC) | -3.86% |
| Return on Capital Employed (ROCE) | -7.30% |
| Revenue Per Employee | $380,067 |
| Profits Per Employee | -$35,897 |
| Employee Count | 11,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.35 |
Taxes
In the past 12 months, BeiGene has paid $134.79 million in taxes.
| Income Tax | 134.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.38% in the last 52 weeks. The beta is 0.35, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +57.38% |
| 50-Day Moving Average | 243.19 |
| 200-Day Moving Average | 218.91 |
| Relative Strength Index (RSI) | 51.61 |
| Average Volume (20 Days) | 362,269 |
Short Selling Information
The latest short interest is 2.03 million, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 2.08M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 2.69% |
| Short Ratio (days to cover) | 3.59 |
Income Statement
In the last 12 months, BeiGene had revenue of $4.18 billion and -$394.86 million in losses. Loss per share was -$3.75.
| Revenue | 4.18B |
| Gross Profit | 3.55B |
| Operating Income | -278.99M |
| Pretax Income | n/a |
| Net Income | -394.86M |
| EBITDA | -104.31M |
| EBIT | -278.99M |
| Loss Per Share | -$3.75 |
Full Income StatementBalance Sheet
The company has $2.52 billion in cash and $1.10 billion in debt, giving a net cash position of $1.42 billion or $11.97 per share.
| Cash & Cash Equivalents | 2.52B |
| Total Debt | 1.10B |
| Net Cash | 1.42B |
| Net Cash Per Share | $11.97 |
| Equity (Book Value) | 3.47B |
| Book Value Per Share | 32.18 |
| Working Capital | 1.89B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $162.93 million and capital expenditures -$376.22 million, giving a free cash flow of -$215.11 million.
| Operating Cash Flow | 162.93M |
| Capital Expenditures | -376.22M |
| Free Cash Flow | -215.11M |
| FCF Per Share | -$1.82 |
Full Cash Flow StatementMargins
Gross margin is 84.94%, with operating and profit margins of -6.67% and -9.44%.
| Gross Margin | 84.94% |
| Operating Margin | -6.67% |
| Pretax Margin | -6.22% |
| Profit Margin | -9.44% |
| EBITDA Margin | -2.50% |
| EBIT Margin | -6.67% |
| FCF Margin | n/a |